Ravulizumab for relapse prevention in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report.
Saved in:
| Title: | Ravulizumab for relapse prevention in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report. |
|---|---|
| Authors: | Akkawi N; Neurology, HMS Mirdif Hospital, Dubai, United Arab Emirates., Mohamed EH; Neurology, HMS Mirdif Hospital, Dubai, United Arab Emirates., Shatila A; Neurology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2026 Jun 12; Vol. 13, pp. 1827687. Date of Electronic Publication: 2026 Jun 12 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
